Lifeboat Foundation

NASA has awarded Blue Origin a $35 million contract to further develop a technology that creates solar cells out of lunar regolith — the dust and crushed rock blanketing the moon’s surface.

“[W]e’re inspired and humbled to receive this investment from NASA to advance our innovation,” said Pat Remias, VP of Blue Origin’s Capabilities Directorate. “First we return humans to the moon, then we start to ‘live off the land.’”

Moon or bust: NASA plans to send astronauts to the moon again as soon as 2025, with the goal of establishing a long-term presence on the lunar surface soon after. For that to work, it’s going to need a way to provide astronauts with a steady supply of everything they need to survive and thrive, from food and water to oxygen and electricity.

Berkshire Hathaway said on Tuesday it has shed its holdings in General Motors and Procter & Gamble, and trimmed its stake in Amazon.com, as the conglomerate controlled by billionaire Warren Buffett boosted its cash pile to a record $157.2 billion.

In a regulatory filing detailing its U.S.-listed stock holdings as of Sept. 30, Berkshire reported no holdings in GM and P&G, after reporting stakes of $848 million and $48 million in June, and said it reduced its stake in Amazon by 5%.

Berkshire also appeared to have shed what had been a $621 million stake in Celanese, a specialty materials company.

As a result, he’s built a network of peers who can relate to his challenges, name-dropping Spotify CEO Daniel Ek, who had appeared on the same podcast just a few weeks before, as one of them.

“Daniel Ek doesn’t know the Brian before Airbnb,” Chesky explained. “So maybe he doesn’t know ‘the real me’…but he does know a different ‘real me’ that my childhood friends can’t know, because high school and college friends can’t possibly know what it’s like for me to go through what I’m going through.

Continue reading “Airbnb boss called his CEO network asking if they could hire any of the 1,900 staff he laid off” »

The afterlife Jones made.

For as long as we have had history and likely before, people have contemplated a life after this one, but might we one day create artificial afterlives? And if so, will we create heavens or hells?\
Get Nebula using my link for 40% off an annual subscription: https://go.nebula.tv/isaacarthur\
Watch my exclusive video on Free Will \& Orch OR: https://nebula.tv/videos/isaacarthur–…\
\
Visit our Website: http://www.isaacarthur.net\
Join Nebula: https://go.nebula.tv/isaacarthur\
Support us on Patreon: / isaacarthur \
Support us on Subscribestar: https://www.subscribestar.com/isaac-a…\
Facebook Group: / 1,583,992,725,237,264 \
Reddit: / isaacarthur \
Twitter: / isaac_a_arthur on Twitter and RT our future content.\
SFIA Discord Server: / discord \
\
Listen or Download the audio of this episode from Soundcloud: Episode’s Audio-only version: / artificial-afterlives \
Episode’s Narration-only version: / space-habitats-narration-only \
\
Credits:\
Artificial Afterlives \
Science \& Futurism with Isaac Arthur\
Episode 399, June 15, 2023\
Written, Produced \& Narrated by Isaac Arthur\
\
Editors:\
Dillon Olander\
\
Graphics by: \
Jeremy Jozwik\
Ken York\
\
Music Courtesy of\
Markus Junnikkala, \

Although the complementary FET is still as much as a decade away from commercialization, it’s clearly the future of CMOS.

The Big Three can now all make CFETs—next stop on the Moore’s Law roadmap.

A new way of looking at a misunderstood disease is revolutionizing treatments and transforming lives.

Europe’s health regulator followed the US and UK in backing the first gene-editing therapy to use Crispr technology, a Vertex Pharmaceuticals Inc. and Crispr Therapeutics AG treatment for sickle cell disease.

The European Medicines Agency’s expert panel recommended on Friday authorizing the Vertex and Crispr drug, Casgevy, for people with severe sickle cell disease and another serious hereditary blood disorder, beta-thalassemia, which is traditionally treated with repeated transfusions. Vertex said before the ruling that it had yet to establish a European list price for the one-time therapy, which costs $2.2 million in the US.

The treatment makes precisely targeted changes in patients’ DNA, a months-long process that requires removing bone marrow and a stem cell transplant. In Europe, Vertex said its initial focus will be on countries with the highest numbers of patients, including France, Italy, the UK and Germany.

The area is slated for lithium mining that could endanger the lagoons and the newly discovered formations.

Artificial intelligence researchers claim to have made the world’s first genuine scientific discovery using a large language model (LLM), which is behind ChatGPT and similar programs. This signals a major breakthrough.

The discovery was made by Google DeepMind, an AI research laboratory where scientists are investigating whether LLMs can do more than just repackage information learned in training and actually generate new insights.

Continue reading “Google researchers make AI tech solve math puzzles ‘beyond human knowledge’” »